Literature DB >> 20621188

Proteasomal and autophagic degradative activities in spinal and bulbar muscular atrophy.

Paola Rusmini1, Elena Bolzoni, Valeria Crippa, Elisa Onesto, Daniela Sau, Mariarita Galbiati, Margherita Piccolella, Angelo Poletti.   

Abstract

Spinal and bulbar muscular atrophy (SBMA or Kennedy's disease) is a fatal neurodegenerative disease characterized by the selective loss of motor neurons in the bulbar region of the brain and in the anterior horns of the spinal cord. The disease has been associated to an expansion of a CAG triplet repeat present in the first coding exon of the androgen receptor (AR) gene. SBMA was the first identified member of a large class of neurodegenerative diseases now known as CAG-related diseases, which includes Huntington's disease (HD), several types of spinocerebellar ataxia (SCAs), and dentatorubral and pallidoluysian atrophy (DRPLA). The expanded CAG tract is translated to an aberrantly long polyglutamine tract (ARpolyQ) in the N-terminal region of the AR protein. The elongated polyQ tract seems to confer a neurotoxic gain-of-function to the mutant AR, possibly via the generation of aberrant conformations (misfolding). Protein misfolding is thought to be a trigger of neurotoxicity, since it perturbs a wide variety of motor neuronal functions. The first event is the accumulation of the ARpolyQ into ubiquitinated aggregates in a ligand (testosterone) dependent manner. The mutant ARpolyQ also impairs proteasome functions. The autophagic pathway may be activated to compensate these aberrant events by clearing the mutant ARpolyQ from motor neuronal cells. This review illustrates the mechanisms at the basis of ARpolyQ degradation via the proteasomal and autophagic systems.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621188     DOI: 10.1016/j.nbd.2010.06.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  25 in total

1.  Mutation of the HERC 1 Ubiquitin Ligase Impairs Associative Learning in the Lateral Amygdala.

Authors:  Eva Mª Pérez-Villegas; José V Negrete-Díaz; Mª Elena Porras-García; Rocío Ruiz; Angel M Carrión; Antonio Rodríguez-Moreno; José A Armengol
Journal:  Mol Neurobiol       Date:  2017-01-19       Impact factor: 5.590

2.  Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Satya L Reddy; Diane E Merry; Hiroaki Adachi; Masahisa Katsuno; Gen Sobue; Diane M Robins; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2013-10-22       Impact factor: 6.150

Review 3.  Autophagy in polyglutamine disease: Imposing order on disorder or contributing to the chaos?

Authors:  Constanza J Cortes; Albert R La Spada
Journal:  Mol Cell Neurosci       Date:  2015-03-11       Impact factor: 4.314

Review 4.  The Role of the Protein Quality Control System in SBMA.

Authors:  Paola Rusmini; Valeria Crippa; Riccardo Cristofani; Carlo Rinaldi; Maria Elena Cicardi; Mariarita Galbiati; Serena Carra; Bilal Malik; Linda Greensmith; Angelo Poletti
Journal:  J Mol Neurosci       Date:  2015-11-14       Impact factor: 3.444

Review 5.  Targeted Molecular Therapies for SBMA.

Authors:  Carlo Rinaldi; Bilal Malik; Linda Greensmith
Journal:  J Mol Neurosci       Date:  2015-11-17       Impact factor: 3.444

6.  Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.

Authors:  Paola Rusmini; Katia Cortese; Valeria Crippa; Riccardo Cristofani; Maria Elena Cicardi; Veronica Ferrari; Giulia Vezzoli; Barbara Tedesco; Marco Meroni; Elio Messi; Margherita Piccolella; Mariarita Galbiati; Massimiliano Garrè; Elena Morelli; Thomas Vaccari; Angelo Poletti
Journal:  Autophagy       Date:  2018-11-05       Impact factor: 16.016

Review 7.  Current status of treatment of spinal and bulbar muscular atrophy.

Authors:  Fumiaki Tanaka; Masahisa Katsuno; Haruhiko Banno; Keisuke Suzuki; Hiroaki Adachi; Gen Sobue
Journal:  Neural Plast       Date:  2012-06-07       Impact factor: 3.599

Review 8.  New routes to therapy for spinal and bulbar muscular atrophy.

Authors:  Anna Rocchi; Maria Pennuto
Journal:  J Mol Neurosci       Date:  2013-02-19       Impact factor: 3.444

9.  Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients.

Authors:  Claudia Malacarne; Mariarita Galbiati; Eleonora Giagnorio; Paola Cavalcante; Franco Salerno; Francesca Andreetta; Cinza Cagnoli; Michela Taiana; Monica Nizzardo; Stefania Corti; Viviana Pensato; Anna Venerando; Cinzia Gellera; Silvia Fenu; Davide Pareyson; Riccardo Masson; Lorenzo Maggi; Eleonora Dalla Bella; Giuseppe Lauria; Renato Mantegazza; Pia Bernasconi; Angelo Poletti; Silvia Bonanno; Stefania Marcuzzo
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

10.  Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction.

Authors:  Lenore K Beitel; Carlos Alvarado; Shaza Mokhtar; Miltiadis Paliouras; Mark Trifiro
Journal:  Front Neurol       Date:  2013-05-15       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.